Article Contents ::
- 1 Details About Generic Salt :: Meclizin
- 2 Main Medicine Class:: Antiemetic and antivertigo,anticholinergic
- 3 (MEK-lih-zeen) Antivert, Antrizine, Bonine, Dizmiss, Dramamine II, Meni-D, Ru-Vert-M Vergon, Bonamine Class: Antiemetic and antivertigo/anticholinergic
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Meclizin
Main Medicine Class:: Antiemetic and antivertigo,anticholinergic
(MEK-lih-zeen)
Antivert, Antrizine, Bonine, Dizmiss, Dramamine II, Meni-D, Ru-Vert-M Vergon, Bonamine
Class: Antiemetic and antivertigo/anticholinergic
Drugs Class ::
Action Acts on CNS to decrease vestibular stimulation and depress labyrinthine activity.
Indications for Drugs ::
Indications Prevention and treatment of nausea, vomiting and dizziness of motion sickness; possibly effective treatment for vertigo of vestibular dysfunction origin.
Drug Dose ::
Route/Dosage
Motion Sickness
ADULTS: PO 25–50 mg 1 hr before travel; may repeat q 24 hr during travel.
Vertigo
ADULTS: PO 25–100 mg/day in divided doses.
Contraindication ::
Contraindications Hypersensitivity to cyclizine; asthma; glaucoma; emphysema; chronic pulmonary disease; shortness of breath; difficulty breathing; urinary retention caused by enlarged prostate.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Undetermined. Children: Safety and efficacy not established. Not recommended in children < 2 yr.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Hypotension; tachycardia; palpitations. CNS: Drowsiness; excitation; nervousness; restlessness; insomnia; euphoria; ertigo; hallucinations. DERM: Rash; urticaria. EENT: Dry nose and throat; visual disturbances; tinnitus. GI: Nausea; vomiting; dry mouth; diarrhea; constipation; anorexia. GU: Urinary frequency; urinary retention; difficulty urinating.
Drug Mode of Action ::
Action Acts on CNS to decrease vestibular stimulation and depress labyrinthine activity.
Drug Interactions ::
Interactions
Alcohol, CNS depressants: Additive CNS effects.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note glaucoma and prostatic hypertrophy.
- Monitor for side effects, especially sedation, hypotension, tachycardia and urinary retention.
- Implement safety precautions (eg, keep bed in low position and instruct patient to call for assistance when rising) if patient is experiencing sedation or vertigo.
|
Drug Storage/Management ::
Administration/Storage
- Tablets may be chewed, swallowed whole or allowed to dissolve in water.
- Store at room temperature.
Drug Notes ::
Patient/Family Education
- When given for motion sickness, inform patient that first dose should be taken 1 hr before exposure to motion.
- Instruct patient to take sips of water frequently, suck on ice chips or sugarless hard candy or chew sugarless gum if dry mouth occurs.
- Explain that high-fiber diet and drinking plenty of fluids may help to prevent constipation, which is common side effect.
- Instruct patient to report these symptoms to physician: sedation, dizziness, palpitations, difficulty urinating or urinary retention.
- Instruct patient to notify physician if vomiting increases or becomes severe.
- Advise patient that drug may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness.
- Instruct patient to avoid intake of alcoholic beverages or other CNS depressants.
- Advise patient not to take otc medications or other prescription medications without consulting physician.